AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Find out what items sell best for quick cash. Making informed decisions can help you earn money easily and efficiently.
21,850 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Meta Platforms posted a strong Q1 beat as CEO Mark Zuckerberg outlined a sweeping AI roadmap. The plan centers on per...
An in-depth look at how much SCHD would be required to replace Social Security income, with current yields, market co...
Open Standard's Open USD stablecoin teams with Visa, Stripe, Coinbase and others, promising fee-free minting and reve...
Grail stock surged on hype around early cancer-detection tests, then faded after a mixed trial result. This article a...
Internal documents reveal OpenAI posted $21B in losses on $13B in revenue, signaling a costly push to scale AI at bre...
Navitas Semiconductor, a noted Nvidia partner, posted a dramatic first-half surge in 2026 as its GaN and SiC power de...
IBM is attracting fresh investor attention as its AI infrastructure strategy gains traction. Arvind Krishna’s reshape...
Investors gauge SpaceX’s potential public listing amid a cautious IPO market. History from Meta’s debut suggests hype...
The Trump administration has paused more than $1 billion in Medicaid payments to California and Minnesota amid suspec...
A profitability-screened small-cap ETF is gaining attention as markets trend toward earnings power. The fund offers a...
Pershing Square disclosed a single new equity position this quarter: Meta Platforms. The bet is large enough to tilt ...